Literature DB >> 13363255

Clinical and metabolic effects of delta 1-dehydro-9-alpha-fluoro hydrocortisone acetate.

C B BALLABIO, G SALA, L VILLA.   

Abstract

Entities:  

Keywords:  ADDISON'S DISEASE/therapy; ARTHRITIS, RHEUMATOID/therapy; FLUDROCORTISONE/related compounds; GOUT/therapy

Mesh：

Substances：

Year:  1956        PMID： 13363255      PMCID： PMC1006888          DOI： 10.1136/ard.15.3.237

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  [Metabolic effect of metacortandracin and of 9-alpha-fluorohydrocortisone acetate].

Authors:  G SALA; G D'AMICO; E PASARGIKLIAN; A AMIRA; C B BALLABIO
Journal:  Reumatismo       Date:  1955 May-Jun

2.  Highly potent adrenal cortical steroids: structure and biologic activity.

Authors:  G W THORN; A E RENOLD; W I MORSE; A GOLDFIEN; W J REDDY
Journal:  Ann Intern Med       Date:  1955-11       Impact factor: 25.391

3.  Metacortandracin and 9-alpha-fluoro hydrocortisone acetate in rheumatic diseases.

Authors:  L VILLA; C B BALLABIO; G SALA
Journal:  Ann Rheum Dis       Date:  1955-09       Impact factor: 19.103

4.  Glucocorticoid and mineralocorticoids activities of delta1-fluorohydrocortisone.

Authors:  R O STAFFORD; L E BARNES; B J BOWMAN; M M MEINZINGER
Journal:  Proc Soc Exp Biol Med       Date:  1955-07

5.  STUDIES ON THE MUCOPROTEINS OF HUMAN PLASMA. I. DETERMINATION AND ISOLATION.

Authors:  R J Winzler; A W Devor; J W Mehl; I M Smyth
Journal:  J Clin Invest       Date:  1948-09       Impact factor: 14.808
  5 in total
  2 in total

1.  Fludrocortisone for orthostatic hypotension.

Authors:  Stephanie Veazie; Kim Peterson; Yasmin Ansari; Kathryn A Chung; Christopher H Gibbons; Satish R Raj; Mark Helfand
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17

2.  Oral Fludrocortisone Test for Salt-Sensitive Screening in Hypertensive Patients: A Randomized Crossover Trial.

Authors:  Andrea Pio-Abreu; Isac de Castro; Giovanio Vieira da Silva; Katia Coelho Ortega; Decio Mion
Journal:  Int J Hypertens       Date:  2018-11-15       Impact factor: 2.420
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.